# Vascular invasion-associated gene expression is detectable in pre-surgical biopsies of stage I lung adenocarcinoma

**Authors:** Dylan Steiner, Lila Sultan, Travis Sullivan, Hanqiao Liu, Xiaohui Xiao, Ashley LeClerc, Savannah Melvin, Yuriy O. Alekseyev, Gang Liu, Sarah A. Mazzilli, Jiarui Zhang, Kei Suzuki, Kimberly Rieger-Christ, Eric J. Burks, Jennifer Beane, Marc E. Lenburg

PMC · DOI: 10.1038/s41467-026-70600-2 · 2026-03-24

## TL;DR

This study identifies gene expression patterns linked to vascular invasion in early-stage lung cancer, detectable in pre-surgery biopsies.

## Contribution

The study introduces a gene signature for vascular invasion detectable in limited biopsy samples, enabling preoperative risk assessment.

## Key findings

- A VI-associated gene signature was identified using bulk RNA sequencing and spatial transcriptomics.
- The predictor derived from the signature correlates with vascular invasion and recurrence in validation cohorts.
- Predictor scores from pre-surgical biopsies show promising discrimination of vascular invasion.

## Abstract

Microscopic vascular invasion (VI) predicts recurrence and benefit from lobectomy in stage I lung adenocarcinoma (LUAD) but cannot be accurately predicted before surgery. Thus, biomarkers that identify this aggressive tumor subset are needed. Here, we show that VI in stage I LUAD is associated with reproducible gene expression programs detectable beyond the invasive focus. Using bulk RNA sequencing of 162 resected tumors and spatial transcriptomics in a subset, we identify and characterize a VI-associated gene signature. A predictor derived from this signature is associated with VI and recurrence in an independent validation cohort and is robust to intra-tumor heterogeneity in multiregional sampling data. In a cohort of pre-surgical biopsies, predictor scores correlate with matched resections and show promising discrimination of VI. These findings indicate that VI-associated transcriptional changes extend across the tumor and are detectable in limited biopsy material, supporting further validation for preoperative risk stratification in stage I LUAD.

Microscopic vascular invasion is an indicator of tumour recurrence in lung adenocarcinoma but is challenging to diagnose. Here, the authors use spatial transcriptomics and bulk RNA-seq to identify gene expression changes associated with vascular invasion that are detectable beyond the invasion site.

## Linked entities

- **Diseases:** lung adenocarcinoma (MONDO:0005061)

## Full-text entities

- **Genes:** TENM1 (teneurin transmembrane protein 1) [NCBI Gene 10178] {aka ODZ1, ODZ3, TEN-M1, TEN1, TNM, TNM1}
- **Diseases:** OS (MESH:C567932), non-mucinous adenocarcinoma (MESH:D002288), STAS (MESH:D004618), LVI (MESH:D009361), epithelial tumor (MESH:D002277), endometrial cancer (MESH:D016889), LMP adenocarcinoma (MESH:D000230), NST (MESH:D012678), I (MESH:D006969), lung cancer (MESH:D008175), carcinogenesis (MESH:D063646), VPI (MESH:D010995), LMP (MESH:C537245), metastasis (MESH:D009362), necrosis (MESH:D009336), AIS (MESH:D065311), LI (MESH:D008207), LHMC (MESH:D003428), breast cancer (MESH:D001943), hypoxic (MESH:D002534), II (MESH:C537730), TNM stage I (MESH:D062706), single (MESH:D012640), ovarian cancer (MESH:D010051), I LUAD (MESH:D000077192), thyroid carcinoma (MESH:D013964), LMP tumors (MESH:D009369), hypoxia (MESH:D000860)
- **Chemicals:** DAB (MESH:C000469), BioRender (-), ethanol (MESH:D000431), oxygen (MESH:D010100), hematoxylin (MESH:D006416), reactive oxygen species (MESH:D017382), paraffin (MESH:D010232), formalin (MESH:D005557), H&amp;E (MESH:D006371)
- **Species:** Homo sapiens (human, species) [taxon 9606], Oryctolagus cuniculus (domestic rabbit, species) [taxon 9986]

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13013712/full.md

---
Source: https://tomesphere.com/paper/PMC13013712